VAZQUEZ CHRIS (Chief Accounting Officer) sold 7.6% of their position (101.00 shares) of BIODESIX INC on the open market
Open‑market sale worth $1.0K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/11/2026ACC: 0000905148-26-000636
Officer· Chief Accounting Officer
Since Feb 2026
-101.00
Net shares
Net seller
$1.0K
Total sold
1
Open market trades
0B · 1S
4
Total transactions
263.00 acquired · 364.00 disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+263.00
Price / share
—
Trade value
—
% of position
24.5%
2/9/2026
1.07K→1.33K
Common Stock
Direct
Shares
−101.00
Price / share
$10.08
Trade value
$1.02K
% of position
7.6%
2/10/2026
1.33K→1.23K
Total
Net shares
+162.00
Net value
-$1.02K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/9/2026 | M · Option Exercise | +263.00 | — | — | 24.5% | 1.07K | 1.33K |
| Common Stock Direct | 2/10/2026 | S · Sale | −101.00 | $10.08 | $1.02K | 7.6% | 1.33K | 1.23K |
| Total | +162.00 | -$1.02K | ||||||
Derivative Transactions2
Restricted Stock Units
Direct
Converts to
Common Stock
28.00 shares
Shares
−28.00
Strike price
Held after
0.00
Exercisable
—
2/9/2026
Restricted Stock Units
Direct
Converts to
Common Stock
235.00 shares
Shares
−235.00
Strike price
Held after
234.00
Exercisable
—
2/9/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock28.00 shares | 2/9/2026 | M · Option Exercise | −28.00 | — | 0.00 | |
| Restricted Stock Units Direct | Common Stock235.00 shares | 2/9/2026 | M · Option Exercise | −235.00 | — | 234.00 |